Research output per year
Research output per year
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Attention for sex in COVID-19 trials: a review of regulatory dossiers
de Vries, S. T., Starokozhko, V., Schellens, I. M. M., Wijnans, L., Enzmann, H., Cavaleri, M. & Mol, P. G. M., 18-Mar-2022, (E-pub ahead of print) In: BMJ Global Health. 7, 3, 9 p., 008173.Research output: Contribution to journal › Review article › Academic › peer-review
Open AccessFile -
Biomarker qualification at the European Medicines Agency: a review of biomarker qualification procedures from 2008 to 2020
Bakker, E., Hendrikse, N. M., Ehmann, F., Van der Meer, D. S., Llinares Garcia, J., Vetter, T., Starokozhko, V. & Mol, P. G. M., 9-Feb-2022, (E-pub ahead of print) In: Clinical Pharmacology & Therapeutics. 32 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile19 Downloads (Pure) -
Handling of New Drug Safety Information in the Dutch Hospital Setting: A Mixed Methods Approach
de Vries, E., Bakker, E., Francisca, R. D. C., Croonen, S., Denig, P. & Mol, P. G. M., 29-Mar-2022, (E-pub ahead of print) In: Drug Safety. 10 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile5 Downloads (Pure) -
Medication adherence in registration trials supporting the approval of new medicines in the European Union
Mantila, K. M., Mol, P. G. M., Pasmooij, M., Hallgreen, C. E. & van Boven, J. F. M., 1-Feb-2022, In: International journal of clinical pharmacy. 44, 1, p. 279-280 2 p.Research output: Contribution to journal › Meeting Abstract › Academic
-
Modified Delphi procedure-based expert consensus on endpoints for an international disease registry for Metachromatic Leukodystrophy: The European Metachromatic Leukodystrophy initiative (MLDi)
Schoenmakers, D. H., Beerepoot, S., van den Berg, S., Adang, L., Bley, A., Boelens, J-J., Fumagalli, F., Goettsch, W. G., Gronborg, S., Groeschel, S., van Hasselt, P. M., Hollak, C. E. M., Lindemans, C., Mochel, F., Mol, P. G. M., Sevin, C., Zerem, A., Schols, L. & Wolf, N., 14-Feb-2022, (E-pub ahead of print) In: Orphanet journal of rare diseases. 17, 1, 14 p., 48.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Downloads (Pure)
-
Drug Approval: what regulatory tools.
Peter G. M. Mol (Keynote speaker)
15-Nov-2018Activity: Talk and presentation › Professional or public presentation › Popular
-
Versnelde beschikbaarheid van geneesmiddelen door ketensamenwerking. Een Europees CBG perspectief.
Peter G. M. Mol (Invited speaker)
13-Jun-2018Activity: Talk and presentation › Academic presentation › Academic
-
Drug Approval & patient preference elicitation.
Peter G. M. Mol (Invited speaker)
25-Oct-2018 → 26-Oct-2018Activity: Talk and presentation › Academic presentation › Academic
-
Targeting NASH, what is the impact on cardiovascular outcomes? A regulator’s perspective
Peter G. M. Mol (Invited speaker)
Feb-2018Activity: Talk and presentation › Academic presentation › Academic
-
Value and potential of patient registries: Patient Registry Initiative & European Cystic Fibrosis Society Patient Registry
Peter G. M. Mol (Invited speaker)
9-Feb-2018Activity: Talk and presentation › Academic presentation › Academic
Prizes
-
Among the most popular publications in Drug Safety in 2017
de Vries, Sieta (Recipient) & Mol, Peter (Recipient), 2017
Prize: Other distinction › Academic
-
Among the most popular scientific papers in Drug Safety 2018
de Vries, Sieta (Recipient), Mol, Peter (Recipient) & Denig, Petra (Recipient), 2018
Prize: Other distinction › Academic
-
Among the most popular scientific papers in Drug Safety 2019
de Vries, Sieta (Recipient), Mol, Peter (Recipient) & Denig, Petra (Recipient), 2019
Prize: Other distinction › Academic
-
Nomination of Top downloaded paper 2018-2019 in BJCP
de Vries, Sieta (Recipient), Denig, Petra (Recipient), Mol, Peter (Recipient) & van Puijenbroek, Eugène (Recipient), 30-Apr-2019
Prize: Other distinction › Academic